Nicardipine inhibits N-type calcium channels in dbcAMP-differentiated neuroblastoma x glioma hybrid cells (NG 108-15 cells)

Acta Pharmacologica Sinica

Volumn 20, Issue 2, 1999, Pages 117-120

  Li, Sheng Nan ^a,b   Bräter, Manfred ^a   Andreas, Klaus ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Calcium channels; Cyclic AMP; Dihydropyridines; Fura 2; NG 108 15 cells; Nicardipine; Nifedipine

Indexed keywords

BUCLADESINE; CALCIUM CHANNEL; CALCIUM ION; NICARDIPINE; NIFEDIPINE;

ARTICLE; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; GLIOMA CELL; HYBRID CELL; NEUROBLASTOMA CELL; TUMOR CELL LINE;

BUCLADESINE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL TRANSFORMATION, NEOPLASTIC; GLIOMA; HUMANS; HYBRID CELLS; NEUROBLASTOMA; NICARDIPINE; NIFEDIPINE; TUMOR CELLS, CULTURED;

EID: 0033048325     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Li SN, Bräter M, Andreas K. Nimodipine and nitrendipine inhibit N-type calcium channels in dibutyryl cAMP-differentiated neuroblastoma × glioma hybrid (NG 108-15) cells. Neurosci Lett 1997; 230: 85-8.
2. 2+ channels in rat pituitary melanotropic cells. Eur J Pharmacol 1996; 311: 293-304.
3. Diochot S, Richard S, Baldy-Moulinier M, Nargeot J, Valmier J. Dihydropyridines, phenylalkylamines and benzothiazepines block N-, P/Q- and R-type calcium currents. Pflügers Arch 1995; 431: 10-9.
4. Jones SW, Jacobs LS. Dihydropyridine actions on calcium currents of frog sympathetic neurons. J Neurosci 1990; 10: 2261-7.
5. Valentino K, Newcomb R, Gadbois T, Singh T, Bowersox S, Bitner S, et al. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci USA 1993; 90: 7894-7.
6. Zhao Q, Smith ML, Siesjö BK. The omega-conopeptide SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischemia. Acta Physiol Scand 1994; 150: 459-61.
7. Bowersox SS, Singh T, Luther RR. Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats. Brain Res 1997; 747: 343-7.
8. 2+-channel blocker prevents CA1 injury 24h following severe forebrain ischemia and reduces infarction following focal ischemia. J Cereb Blood Flow Metab 1994; 14: 903-10.
9. Yamada K, Teraoka T, Morita S, Hasegawa T, Nabeshima T. Omega-conotoxin GVIA protects against ischemia-induced neuronal death in the Mongolian gerbil but not against quinolinic acid-induced neurotoxicity in the rat. Neuropharmacology 1994; 33: 251-4.
10. Chueh SH, Kao LS, Liu YT. Enhanced calcium signalling events in neuroblastoma × glioma hybrid NG108-15 cells after treatment with dibutyryl cyclic AMP. Brain Res 1994; 660; 81-7.
11. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
12. + exchange; a pharmacological study. Biochim Biophys Acta 1989; 979: 305-10.
13. Freedman SB, Dawson G, Villereal ML, Miller RJ. Identification and characterization of voltage-sensitive calcium channels in neuronal clonal cell lines. J Neurosci 1984; 4: 1453-67.
14. Noronha-Blob L, Richard C, U'Prichard DC. Voltage-sensitive calcium channels in differentiated neuroblastoma × glioma hybrid (NG108-15) cells; characterization by quin 2 fluorescence. J Neurochem 1988; 50; 1381-90.